SIMCERE PHARMAC. GRP LTD (S2P) — Working Capital to Net Assets Ratio
SIMCERE PHARMAC. GRP LTD (S2P) has a Working Capital to Net Assets ratio of 43.0% as of December 2025. Working capital of €4.04 Billion (current assets of €7.39 Billion minus current liabilities of €3.35 Billion) is measured against net assets of €9.41 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See S2P financial flexibility index to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
SIMCERE PHARMAC. GRP LTD Working Capital to Net Assets (2021–2025)
This chart shows how SIMCERE PHARMAC. GRP LTD's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 43.0%, reflecting working capital of €4.04 Billion against net assets of €9.41 Billion EUR. See SIMCERE PHARMAC. GRP LTD defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for SIMCERE PHARMAC. GRP LTD (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for SIMCERE PHARMAC. GRP LTD from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see SIMCERE PHARMAC. GRP LTD (S2P) total market value.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 43.0% | €4.04 Billion | €9.41 Billion | €7.39 Billion | €3.35 Billion | ▲ +4.2 pp |
| 2024 | 38.7% | €2.74 Billion | €7.07 Billion | €5.47 Billion | €2.73 Billion | ▼ -2.1 pp |
| 2023 | 40.9% | €2.95 Billion | €7.22 Billion | €5.64 Billion | €2.69 Billion | ▲ +6.0 pp |
| 2022 | 34.9% | €2.49 Billion | €7.15 Billion | €5.46 Billion | €2.97 Billion | ▲ +5.2 pp |
| 2021 | 29.6% | €1.92 Billion | €6.46 Billion | €4.98 Billion | €3.06 Billion | — |